Delivery of drugs

Aikaterini Lalatsa

Delivery of drugs

Aikaterini Lalatsa (Inventor)

Research output: Patent

Abstract

The present invention relates to a composition comprising a hydrophilic drug and an amphiphilic carbohydrate compound for use in therapy wherein the composition is intranasally administered to the human or animal body. The composition can be used to treat a variety of disorders, including schizophrenia, obesity, pain and sleep disorders, psychiatric diseases, neurodegenerative conditions, brain cancers and infective diseases.

Original language	English
Patent number	PCT/GB2014/053254,
IPC	A61K 47/36 (2006.01), A61K 38/08 (2006.01)
Priority date	4/11/14
Publication status	Published - 7 May 2015

Keywords

Peptide, Nanomedicines, Nasal

Access to Document

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2015063510&recNum=1&office=&queryString=FP%3A%28lalatsa%29&prevFilter=&sortOption=Pub+Date+Desc&maxRec=6Licence: Unspecified

Cite this

@misc{9025f2f7b8e54bf6ac521f3123a8c79e,

title = "Delivery of drugs",

abstract = "The present invention relates to a composition comprising a hydrophilic drug and an amphiphilic carbohydrate compound for use in therapy wherein the composition is intranasally administered to the human or animal body. The composition can be used to treat a variety of disorders, including schizophrenia, obesity, pain and sleep disorders, psychiatric diseases, neurodegenerative conditions, brain cancers and infective diseases.",

keywords = "Peptide, Nanomedicines, Nasal",

author = "Aikaterini Lalatsa",

year = "2015",

month = may,

day = "7",

language = "English",

type = "Patent",

note = "PCT/GB2014/053254, ; A61K 47/36 (2006.01), A61K 38/08 (2006.01) ",

}

TY - PAT

T1 - Delivery of drugs

AU - Lalatsa, Aikaterini

PY - 2015/5/7

Y1 - 2015/5/7

N2 - The present invention relates to a composition comprising a hydrophilic drug and an amphiphilic carbohydrate compound for use in therapy wherein the composition is intranasally administered to the human or animal body. The composition can be used to treat a variety of disorders, including schizophrenia, obesity, pain and sleep disorders, psychiatric diseases, neurodegenerative conditions, brain cancers and infective diseases.

AB - The present invention relates to a composition comprising a hydrophilic drug and an amphiphilic carbohydrate compound for use in therapy wherein the composition is intranasally administered to the human or animal body. The composition can be used to treat a variety of disorders, including schizophrenia, obesity, pain and sleep disorders, psychiatric diseases, neurodegenerative conditions, brain cancers and infective diseases.

KW - Peptide, Nanomedicines, Nasal

M3 - Patent

M1 - PCT/GB2014/053254,

ER -

Delivery of drugs

Abstract

Keywords

Access to Document

Fingerprint

Cite this